SARS-CoV-2 Mu variant


The Mu variant is a variant of SARS-CoV-2. It was first detected in Colombia in January 2021 and was classified by the World Health Organization as a variant of interest on August 30, 2021. On March 9, 2022, the organization has de-escalated the Mu variant and its subvariants to previously circulating variants of interest.
With outbreaks of the Mu variant reported in South America and Europe since detection, the WHO said the variant has mutations that indicate a risk of resistance to the current vaccines and stressed that further studies are needed to better understand it.
The B.1.621 lineage has a sublineage, designated B.1.621.1 under the PANGO nomenclature, which has also been detected in multiple countries worldwide.

Classification

Within the PANGOLIN naming scheme, the variant was designated as B.1.621. On July 1, 2021, Public Health England designated the lineage as a variant under investigation, calling it VUI-21JUL-1. On August 30, 2021, it was classified as a variant of interest by the World Health Organization and assigned it the name Mu, following their Greek-letter naming system. The lineage, including its sublineage B.1.621.1, is assigned to Nextstrain clade 21H and GISAID clade GH. On March 9, 2022, the WHO reclassified the Mu variant as a previously circulating VOI as it has been demonstrated to no longer pose a substantially greater risk to global public health compared to other circulating SARS-CoV-2 variants.

Mutations

The Mu genome has a total number of 21 mutations, including 9 amino acid mutations, all of which are in the virus's spike protein code: T95I, Y144S, Y145N, R346K, E484K or the escape mutation, N501Y, D614G, P681H, and D950N. It has an insertion of one amino acid at position 144/145 of the spike protein, giving a total mutation YY144–145TSN. That mutation is conventionally notated as Y144S and Y145N because insertions would break a lot of comparison tools. It also features a frame-shift deletion of four nucleotides in ORF3a that generates a stop codon two amino acids. The mutation is labeled as V256I, N257Q, and P258*. The list of defining mutations are: S: T95I, Y144S, Y145N, R346K, E484K, N501Y, D614G, P681H, and D950N; ORF1a: T1055A, T1538I, T3255I, Q3729R; ORF1b: P314L, P1342S; N: T205I, ORF3a: Q57H, V256I, N257Q, P258*; ORF8: T11K, P38S, S67F. Mutations in viruses are not new. All viruses, including SARS-CoV-2, undergo change over time. Most of these changes are inconsequential, but some can alter properties to make these viruses more virulent or escape the treatment or vaccines.
On August 31, 2021, the WHO released an update which stated that the "Mu variant has a constellation of mutations that indicate potential properties of immune escape," noting that preliminary studies showed some signs of this but that "this needs to be confirmed by further studies."
One such study conducted in a lab in Rome tested the effectiveness of sera collected from recipients of the BioNTech-Pfizer vaccine against the Mu variant, and found that "neutralization of SARS-CoV-2 B.1.621 lineage was robust," albeit at a lower level than that observed against the B.1 variant.
GeneAmino acid
ORF1aT1055A
ORF1aT1538I
ORF1aT3255I
ORF1aQ3729R
ORF1bP314L
ORF1bP1342S
ST95I
SY144S
SY145N
SR346K
SE484K
SN501Y
SD614G
SP681H
SD950N
ORF3aQ57H
ORF3adel257/257
ORF8T11K
ORF8P38S
ORF8S67F
NT205I

History

First identified in Colombia in January 2021, the Mu variant was later categorized as a variant of interest in August 2021. Retrospective analysis revealed that it had already been present in multiple samples collected since late 2020, indicating that it had been circulating since the second wave of the Colombian epidemic. Its prevalence grew rapidly, eventually becoming the dominant strain during the third epidemic wave, highlighting its significant role in the country's COVID-19 epidemiological landscape.

August 2021

August 6:
  • Reuters reported that seven vaccinated elderly residents of a nursing home in the town of Zaventem in Belgium died after contracting the Mu variant.
August 30:
  • Lineage B.1.621 has been officially recognized by the World Health Organization as a variant of interest and is termed the Mu variant.
  • Japan confirmed its first two cases of the Mu variant. The variant was detected in a woman in her 40s who arrived on June 26 from the United Arab Emirates. Another woman in her 50s who arrived in Japan on July 5 from the United Kingdom also had the Mu variant. Both patients were asymptomatic.

    September 2021

September 2:
  • The Central Epidemic Command Center announced Taiwan's first ever case of the Mu variant. The patient is a Taiwanese woman in her 60s who returned from the United States and already had 2 doses of the Pfizer vaccine. She had received the first dose of the Pfizer vaccine in the United States on July 5 and the second on July 26. When she returned to Taiwan on August 3, she did not report any symptoms, but a test administered at the airport revealed that she was positive for COVID-19.
  • Guatemala reported its first two cases of the Mu variant in two female patients, aged 19 and 25. Both patients had no travel and vaccination history. The patients reside in the central department of Guatemala, where the capital, Guatemala City, is located.
  • Infectious-disease expert Anthony Fauci announced that while the United States government was "keeping a very close eye" on the Mu variant, it was not an "immediate threat right now" within the U.S. The Delta variant was accounting for 99% of U.S. cases of COVID.
September 3:
  • Greece confirmed its first six cases of the Mu variant in the country. Four of them are imported cases.
  • Hong Kong confirmed its first three cases of the Mu variant. Two of the patients – a 19-year-old man and a 22-year-old woman had flown in from Colombia and were confirmed to have the Mu variant in early June, while the other, a 26-year-old woman, arrived from the United States. She was confirmed infected on July 24. Hong Kong also reported four new imported COVID-19 cases, all involving domestic workers who arrived from the Philippines.
  • South Korea confirmed the country's first cases of the Mu variant. The Korea Disease Control and Prevention Agency said that the variant was confirmed in three imported cases from Mexico, United States and Colombia.
September 4:
September 7:
  • The U.S. Virgin Islands confirmed the presence of the Mu variant in the country.
  • Turkey has detected its first Mu variant cases. It has been identified in at least two individuals.
September 8:
  • Saint Vincent and the Grenadines confirmed the presence of the Mu variant in the country with five cases reported, which have been detected between July 9 and August 19, 2021.
September 9:
  • Twenty-six cases of the Mu variant have been confirmed in Jamaica from a total of 92 samples which were sent for testing to the Atlanta-based Centers for Disease Control on August 21.
  • Argentina confirmed the presence of the Mu variant in the country with one case reported. The patient is a 33-year-old woman who previously had two doses of the COVID-19 vaccine. The patient resides in the San Martín department, in the north of the province of Salta. The patient presented mild symptoms and did not require hospitalization.
September 16:
September 18:
  • Finland detected its first cases of the Mu variant in the country.

    Statistics